Drug & intervention

erlotinib hydrochloride

RxCUI 477320

Clinical trials74
Recruiting0
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

40 shown
Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung CancerNCT03137771 · 2017-04-07
ACTIVE_NOT_RECRUITING
Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLCNCT03074864 · 2017-02-27
UNKNOWN
Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung CancerNCT02535338 · 2016-04-11
COMPLETED
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)NCT02193282 · 2015-02-11
ACTIVE_NOT_RECRUITING
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung CancerNCT02154490 · 2014-07-08
COMPLETED
Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker MatchesNCT02926638 · 2014-06-16
TERMINATED
Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or GefitinibNCT01928160 · 2014-06-01
WITHDRAWN
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung CancerNCT01857271 · 2013-11-01
TERMINATED
Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung CancerNCT01839955 · 2013-09-01
COMPLETED
INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung CancerNCT01911507 · 2013-08-27
COMPLETED
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung CancerNCT01866410 · 2013-05-20
COMPLETED
Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung CancerNCT01708954 · 2013-02-13
ACTIVE_NOT_RECRUITING
Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)NCT01515969 · 2012-07-01
TERMINATED
Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor MutationsNCT01532089 · 2012-03-16
COMPLETED
Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung CancerNCT01259089 · 2011-04-27
COMPLETED
MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride TherapyNCT01294306 · 2011-02-01
COMPLETED
RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerNCT01193881 · 2010-08-01
TERMINATED
Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never SmokersNCT01344824 · 2010-03-01
COMPLETED
MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous ChemotherapyNCT01068587 · 2010-01-21
COMPLETED
Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung CancerNCT00976677 · 2010-01-01
TERMINATED
Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the LungNCT01013831 · 2009-10-01
TERMINATED
Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast CancerNCT01013506 · 2009-08-01
WITHDRAWN
Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung CancerNCT00955695 · 2009-05-01
UNKNOWN
Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain MetastasesNCT00738335 · 2009-01-01
WITHDRAWN
S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00661193 · 2008-12-01
COMPLETED
Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerNCT00778167 · 2008-10-01
COMPLETED
Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung CancerNCT00738881 · 2008-10-01
TERMINATED
Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to ChemotherapyNCT00801385 · 2008-09-01
UNKNOWN
QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLCNCT00385398 · 2008-07-01
WITHDRAWN
Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast CancerNCT00733408 · 2008-04-23
COMPLETED
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryNCT00553462 · 2008-03-01
COMPLETED
Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung CancerNCT00989690 · 2008-02-01
UNKNOWN
Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00660816 · 2008-01-01
COMPLETED
WBRT & Erlotinib in Advanced NSCLC and Brain MetastasesNCT00554775 · 2008-01-01
TERMINATED
Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast CancerNCT00503841 · 2007-12-01
TERMINATED
Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung CancerNCT00499655 · 2007-11-01
COMPLETED
Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00550537 · 2007-10-01
COMPLETED
S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar CarcinomaNCT00436332 · 2007-07-01
COMPLETED
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT01557959 · 2007-07-01
COMPLETED
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung CancerNCT00445848 · 2007-07-01
COMPLETED

Conditions being studied

Lung Cancer25Stage IV Non-small Cell Lung Cancer18Stage IIIB Non-small Cell Lung Cancer16Recurrent Non-small Cell Lung Cancer15Breast Cancer8Recurrent Non-Small Cell Lung Carcinoma7Stage IIIA Non-Small Cell Lung Cancer6Adenocarcinoma of the Lung4Recurrent Squamous Cell Carcinoma of the Hypopharynx4Recurrent Squamous Cell Carcinoma of the Larynx4Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity4Recurrent Squamous Cell Carcinoma of the Nasopharynx4Recurrent Squamous Cell Carcinoma of the Oropharynx4Stage IV Lung Non-Small Cell Cancer AJCC v74Stage IV Squamous Cell Carcinoma of the Hypopharynx4Stage IV Squamous Cell Carcinoma of the Nasopharynx4Large Cell Lung Cancer3Lung Adenocarcinoma3Metastatic Cancer3Non-small Cell Lung Cancer3

Leading sponsors

National Cancer Institute (NCI)25Vanderbilt-Ingram Cancer Center6SWOG Cancer Research Network5Jonsson Comprehensive Cancer Center4UNC Lineberger Comprehensive Cancer Center3University of California, Davis3Albert Einstein College of Medicine2Alliance for Clinical Trials in Oncology2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2University College, London2Academic and Community Cancer Research United1Barbara Ann Karmanos Cancer Institute1Case Comprehensive Cancer Center1City of Hope Medical Center1Guangdong Provincial People's Hospital1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.